Global Diabetic Retinopathy Market Professional Survey Report 2016
- QYR633704
- 116 Pages
- July 2016
- Healthcare
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bayer
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alimera Sciences
Ampio Pharmaceuticals
Kowa Group
Ohr Pharmaceutical
Promedior
PSivida
Quark Pharmaceuticals
ThromboGenics
By types, the market can be split into
Corticosteroids drugs
Anti-VEGF drugs
Others
By Application, the market can be split into
Application 1
Application 2
Application 3
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global Diabetic Retinopathy Market Professional Survey Report 2016
1 Industry Overview of Diabetic Retinopathy
1.1 Definition and Specifications of Diabetic Retinopathy
1.1.1 Definition of Diabetic Retinopathy
1.1.2 Specifications of Diabetic Retinopathy
1.2 Classification of Diabetic Retinopathy
1.2.1 Corticosteroids drugs
1.2.2 Anti-VEGF drugs
1.2.3 Others
1.3 Applications of Diabetic Retinopathy
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Diabetic Retinopathy
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Diabetic Retinopathy
2.3 Manufacturing Process Analysis of Diabetic Retinopathy
2.4 Industry Chain Structure of Diabetic Retinopathy
3 Technical Data and Manufacturing Plants Analysis of Diabetic Retinopathy
3.1 Capacity and Commercial Production Date of Global Diabetic Retinopathy Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Diabetic Retinopathy Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Diabetic Retinopathy Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Diabetic Retinopathy Major Manufacturers in 2015
4 Global Diabetic Retinopathy Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global Diabetic Retinopathy Capacity and Growth Rate Analysis
4.2.2 2015 Diabetic Retinopathy Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global Diabetic Retinopathy Sales and Growth Rate Analysis
4.3.2 2015 Diabetic Retinopathy Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global Diabetic Retinopathy Sales Price
4.4.2 2015 Diabetic Retinopathy Sales Price Analysis (Company Segment)
5 Diabetic Retinopathy Regional Market Analysis
5.1 North America Diabetic Retinopathy Market Analysis
5.1.1 North America Diabetic Retinopathy Market Overview
5.1.2 North America 2011-2016E Diabetic Retinopathy Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Diabetic Retinopathy Sales Price Analysis
5.1.4 North America 2015 Diabetic Retinopathy Market Share Analysis
5.2 China Diabetic Retinopathy Market Analysis
5.2.1 China Diabetic Retinopathy Market Overview
5.2.2 China 2011-2016E Diabetic Retinopathy Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Diabetic Retinopathy Sales Price Analysis
5.2.4 China 2015 Diabetic Retinopathy Market Share Analysis
5.3 Europe Diabetic Retinopathy Market Analysis
5.3.1 Europe Diabetic Retinopathy Market Overview
5.3.2 Europe 2011-2016E Diabetic Retinopathy Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Diabetic Retinopathy Sales Price Analysis
5.3.4 Europe 2015 Diabetic Retinopathy Market Share Analysis
5.4 Southeast Asia Diabetic Retinopathy Market Analysis
5.4.1 Southeast Asia Diabetic Retinopathy Market Overview
5.4.2 Southeast Asia 2011-2016E Diabetic Retinopathy Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E Diabetic Retinopathy Sales Price Analysis
5.4.4 Southeast Asia 2015 Diabetic Retinopathy Market Share Analysis
5.5 Japan Diabetic Retinopathy Market Analysis
5.5.1 Japan Diabetic Retinopathy Market Overview
5.5.2 Japan 2011-2016E Diabetic Retinopathy Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Diabetic Retinopathy Sales Price Analysis
5.5.4 Japan 2015 Diabetic Retinopathy Market Share Analysis
5.6 India Diabetic Retinopathy Market Analysis
5.6.1 India Diabetic Retinopathy Market Overview
5.6.2 India 2011-2016E Diabetic Retinopathy Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Diabetic Retinopathy Sales Price Analysis
5.6.4 India 2015 Diabetic Retinopathy Market Share Analysis
6 Global 2011-2016E Diabetic Retinopathy Segment Market Analysis (by Type)
6.1 Global 2011-2016E Diabetic Retinopathy Sales by Type
6.2 Different Types of Diabetic Retinopathy Product Interview Price Analysis
6.3 Different Types of Diabetic Retinopathy Product Driving Factors Analysis
6.3.1 Corticosteroids drugs of Diabetic Retinopathy Growth Driving Factor Analysis
6.3.2 Anti-VEGF drugs of Diabetic Retinopathy Growth Driving Factor Analysis
6.3.3 Others of Diabetic Retinopathy Growth Driving Factor Analysis
7 Global 2011-2016E Diabetic Retinopathy Segment Market Analysis (by Application)
7.1 Global 2011-2016E Diabetic Retinopathy Consumption by Application
7.2 Different Application of Diabetic Retinopathy Product Interview Price Analysis
7.3 Different Application of Diabetic Retinopathy Product Driving Factors Analysis
7.3.1 Application 1 Diabetic Retinopathy Growth Driving Factor Analysis
7.3.2 Application 2 Diabetic Retinopathy Growth Driving Factor Analysis
7.3.3 Application 3 Diabetic Retinopathy Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Diabetic Retinopathy
8.1 Bayer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Bayer 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bayer 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.2 F. Hoffmann-La Roche
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 F. Hoffmann-La Roche 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 F. Hoffmann-La Roche 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Novartis 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.4 Regeneron Pharmaceuticals
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Regeneron Pharmaceuticals 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Regeneron Pharmaceuticals 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.5 Alimera Sciences
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Alimera Sciences 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Alimera Sciences 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.6 Ampio Pharmaceuticals
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Ampio Pharmaceuticals 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Ampio Pharmaceuticals 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.7 Kowa Group
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Kowa Group 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Kowa Group 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.8 Ohr Pharmaceutical
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Ohr Pharmaceutical 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Ohr Pharmaceutical 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.9 Promedior
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Promedior 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Promedior 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.10 PSivida
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 PSivida 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 PSivida 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.11 Quark Pharmaceuticals
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Quark Pharmaceuticals 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Quark Pharmaceuticals 2015 Diabetic Retinopathy Business Region Distribution Analysis
8.12 ThromboGenics
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 ThromboGenics 2015 Diabetic Retinopathy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 ThromboGenics 2015 Diabetic Retinopathy Business Region Distribution Analysis
9 Development Trend of Analysis of Diabetic Retinopathy Market
9.1 Global Diabetic Retinopathy Market Trend Analysis
9.1.1 Global 2016-2021 Diabetic Retinopathy Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Diabetic Retinopathy Sales Price Forecast
9.2 Diabetic Retinopathy Regional Market Trend
9.2.1 North America 2016-2021 Diabetic Retinopathy Consumption Forecast
9.2.2 China 2016-2021 Diabetic Retinopathy Consumption Forecast
9.2.3 Europe 2016-2021 Diabetic Retinopathy Consumption Forecast
9.2.4 Southeast Asia 2016-2021 Diabetic Retinopathy Consumption Forecast
9.2.5 Japan 2016-2021 Diabetic Retinopathy Consumption Forecast
9.2.6 India 2016-2021 Diabetic Retinopathy Consumption Forecast
9.3 Diabetic Retinopathy Market Trend (Product Type)
9.4 Diabetic Retinopathy Market Trend (Application)
10 Diabetic Retinopathy Marketing Type Analysis
10.1 Diabetic Retinopathy Regional Marketing Type Analysis
10.2 Diabetic Retinopathy International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Diabetic Retinopathy by Regions
10.4 Diabetic Retinopathy Supply Chain Analysis
11 Consumers Analysis of Diabetic Retinopathy
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Diabetic Retinopathy Market Professional Survey Report 2016
Figure Picture of Diabetic Retinopathy
Table Product Specifications of Diabetic Retinopathy
Table Classification of Diabetic Retinopathy
Figure Global Production Market Share of Diabetic Retinopathy by Type in 2015
Figure Corticosteroids drugs Picture
Table Major Manufacturers of Corticosteroids drugs
Figure Anti-VEGF drugs Picture
Table Major Manufacturers of Anti-VEGF drugs
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Diabetic Retinopathy
Figure Global Consumption Volume Market Share of Diabetic Retinopathy by Application in 2015
Figure Market Share of Diabetic Retinopathy by Regions
Figure North America Diabetic Retinopathy Market Size (2011-2021)
Figure China Diabetic Retinopathy Market Size (2011-2021)
Figure Europe Diabetic Retinopathy Market Size (2011-2021)
Figure Southeast Asia Diabetic Retinopathy Market Size (2011-2021)
Figure Japan Diabetic Retinopathy Market Size (2011-2021)
Figure India Diabetic Retinopathy Market Size (2011-2021)
Table Diabetic Retinopathy Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Diabetic Retinopathy in 2015
Figure Manufacturing Process Analysis of Diabetic Retinopathy
Figure Industry Chain Structure of Diabetic Retinopathy
Table Capacity (K Dose) and Commercial Production Date of Global Diabetic Retinopathy Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Diabetic Retinopathy Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Diabetic Retinopathy Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Diabetic Retinopathy Major Manufacturers in 2015
Table Global Capacity (K Dose), Sales (K Dose), Price (USD/Dose), Cost (USD/Dose), Sales Revenue (M USD) and Gross Margin of Diabetic Retinopathy 2011-2016
Figure Global 2011-2016E Diabetic Retinopathy Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Diabetic Retinopathy Market Size (Value) and Growth Rate
Table 2011-2016E Global Diabetic Retinopathy Capacity and Growth Rate
Table 2015 Global Diabetic Retinopathy Capacity List (Company Segment)
Table 2011-2016E Global Diabetic Retinopathy Sales and Growth Rate
Table 2015 Global Diabetic Retinopathy Sales List (Company Segment)
Table 2011-2016E Global Diabetic Retinopathy Sales Price
Table 2015 Global Diabetic Retinopathy Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Diabetic Retinopathy 2011-2016 (K Dose)
Figure North America 2011-2016E Diabetic Retinopathy Sales Price (USD/Dose)
Figure North America 2015 Diabetic Retinopathy Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Diabetic Retinopathy 2011-2016 (K Dose)
Figure China 2011-2016E Diabetic Retinopathy Sales Price (USD/Dose)
Figure China 2015 Diabetic Retinopathy Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Diabetic Retinopathy 2011-2016 (K Dose)
Figure Europe 2011-2016E Diabetic Retinopathy Sales Price (USD/Dose)
Figure Europe 2015 Diabetic Retinopathy Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Diabetic Retinopathy 2011-2016 (K Dose)
Figure Southeast Asia 2011-2016E Diabetic Retinopathy Sales Price (USD/Dose)
Figure Southeast Asia 2015 Diabetic Retinopathy Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Diabetic Retinopathy 2011-2016 (K Dose)
Figure Japan 2011-2016E Diabetic Retinopathy Sales Price (USD/Dose)
Figure Japan 2015 Diabetic Retinopathy Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Diabetic Retinopathy 2011-2016 (K Dose)
Figure India 2011-2016E Diabetic Retinopathy Sales Price (USD/Dose)
Figure India 2015 Diabetic Retinopathy Sales Market Share
Table Global 2011-2016E Diabetic Retinopathy Sales by Type
Table Different Types Diabetic Retinopathy Product Interview Price
Table Global 2011-2016E Diabetic Retinopathy Sales by Application
Table Different Application Diabetic Retinopathy Product Interview Price
Table Bayer Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Bayer Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Bayer 2015 Diabetic Retinopathy Business Region Distribution
Table F. Hoffmann-La Roche Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 F. Hoffmann-La Roche Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 F. Hoffmann-La Roche 2015 Diabetic Retinopathy Business Region Distribution
Table Novartis Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Novartis Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Novartis 2015 Diabetic Retinopathy Business Region Distribution
Table Regeneron Pharmaceuticals Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Regeneron Pharmaceuticals Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Regeneron Pharmaceuticals 2015 Diabetic Retinopathy Business Region Distribution
Table Alimera Sciences Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Alimera Sciences Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Alimera Sciences 2015 Diabetic Retinopathy Business Region Distribution
Table Ampio Pharmaceuticals Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Ampio Pharmaceuticals Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Ampio Pharmaceuticals 2015 Diabetic Retinopathy Business Region Distribution
Table Kowa Group Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Kowa Group Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Kowa Group 2015 Diabetic Retinopathy Business Region Distribution
Table Ohr Pharmaceutical Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Ohr Pharmaceutical Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Ohr Pharmaceutical 2015 Diabetic Retinopathy Business Region Distribution
Table Promedior Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Promedior Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Promedior 2015 Diabetic Retinopathy Business Region Distribution
Table PSivida Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 PSivida Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 PSivida 2015 Diabetic Retinopathy Business Region Distribution
Table Quark Pharmaceuticals Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 Quark Pharmaceuticals Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 Quark Pharmaceuticals 2015 Diabetic Retinopathy Business Region Distribution
Table ThromboGenics Information List
Table Type I Diabetic Retinopathy Overview
Table Type II Diabetic Retinopathy Overview
Table Type III Diabetic Retinopathy Overview
Table 2015 ThromboGenics Diabetic Retinopathy Revenue, Sales, Ex-factory Price
Figure 2015 ThromboGenics 2015 Diabetic Retinopathy Business Region Distribution
Figure Global 2016-2021 Diabetic Retinopathy Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Diabetic Retinopathy Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Diabetic Retinopathy Sales Price (USD/Dose) Forecast
Figure North America 2016-2021 Diabetic Retinopathy Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Diabetic Retinopathy Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Diabetic Retinopathy Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Diabetic Retinopathy Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Diabetic Retinopathy Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Diabetic Retinopathy Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Dose) of Diabetic Retinopathy by Types 2016-2021
Table Global Consumption Volume (K Dose) of Diabetic Retinopathy by Applications 2016-2021
Table Traders or Distributors with Contact Information of Diabetic Retinopathy by Regions
Table Part of Interviewees Record List
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
